Standpoint Research Downgrades Zimmer Holdings (ZMH) to Hold; See Near-Term Top
Tweet
Share
E-mailGet Alerts ZMH Hot Sheet
Price: $113.56 +0.26%
Rating Summary:
0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Standpoint Research downgraded Zimmer Holdings (NYSE: ZMH) from Buy to Hold.
Analyst, Ronnie Moas, said, "Zimmer shares are up 6% this morning on a well-received earnings announcement and hit our price target. ZMH has had a nice move since December 19...up 30% and + 1500 bps versus the S&P-500 and that is significant for a low beta name...this may be a near-term top on an absolute and relative basis. In my opinion it will not be before 2013 that we see a $70 quote on these (now) fairly valued shares (for the first time since Q4 2008)."
"We got very aggressive on this medical equipment industry back in August. We added Medtronic (NYSE: MDT), Stryker (NYSE: SYK and ZMH. We then added Baxter (NYSE: BAX) in January to replace MDT that was dropped in December. We remain with open recommendations out on SYK and BAX – both of those names reported well-received quarters this week. Additionally, we remain with an open outstanding recommendation on Hologic (Nasdaaq: HOLX) (from a couple of years ago)."
For an analyst ratings summary and ratings history on Zimmer Holdings click here. For more ratings news on Zimmer Holdings click here.
Shares of Zimmer Holdings closed at $57.75 yesterday.
Analyst, Ronnie Moas, said, "Zimmer shares are up 6% this morning on a well-received earnings announcement and hit our price target. ZMH has had a nice move since December 19...up 30% and + 1500 bps versus the S&P-500 and that is significant for a low beta name...this may be a near-term top on an absolute and relative basis. In my opinion it will not be before 2013 that we see a $70 quote on these (now) fairly valued shares (for the first time since Q4 2008)."
"We got very aggressive on this medical equipment industry back in August. We added Medtronic (NYSE: MDT), Stryker (NYSE: SYK and ZMH. We then added Baxter (NYSE: BAX) in January to replace MDT that was dropped in December. We remain with open recommendations out on SYK and BAX – both of those names reported well-received quarters this week. Additionally, we remain with an open outstanding recommendation on Hologic (Nasdaaq: HOLX) (from a couple of years ago)."
For an analyst ratings summary and ratings history on Zimmer Holdings click here. For more ratings news on Zimmer Holdings click here.
Shares of Zimmer Holdings closed at $57.75 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
- Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
Create E-mail Alert Related Categories
DowngradesRelated Entities
Standard & Poor's, Standpoint Research, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
